Wu, L.; Liu, Y.; Deng, W.; Wu, T.; Bu, L.; Chen, L.
OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC. Int. J. Mol. Sci. 2023, 24, 12904.
https://doi.org/10.3390/ijms241612904
AMA Style
Wu L, Liu Y, Deng W, Wu T, Bu L, Chen L.
OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC. International Journal of Molecular Sciences. 2023; 24(16):12904.
https://doi.org/10.3390/ijms241612904
Chicago/Turabian Style
Wu, Lei, Yuantong Liu, Weiwei Deng, Tianfu Wu, Linlin Bu, and Lei Chen.
2023. "OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC" International Journal of Molecular Sciences 24, no. 16: 12904.
https://doi.org/10.3390/ijms241612904
APA Style
Wu, L., Liu, Y., Deng, W., Wu, T., Bu, L., & Chen, L.
(2023). OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC. International Journal of Molecular Sciences, 24(16), 12904.
https://doi.org/10.3390/ijms241612904